Literature DB >> 690636

Treatment of myoclonus with pheneturide.

C D Ward.   

Abstract

Twenty-one patients with various forms of myoclonus are presented. Phenacemide was given to five patients with considerable benefit to three, but with serious toxic effects in two. Another acetylurea derivative, pheneturide, was given to 19 patients and was well tolerated. Myoclonus was completely or substantially controlled in 12 patients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 690636      PMCID: PMC493102          DOI: 10.1136/jnnp.41.7.598

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy.

Authors:  J W LANCE; R D ADAMS
Journal:  Brain       Date:  1963-03       Impact factor: 13.501

2.  Restless legs syndrome.

Authors:  K A EKBOM
Journal:  Neurology       Date:  1960-09       Impact factor: 9.910

3.  Sudden bodily jerks on falling asleep.

Authors:  I OSWALD
Journal:  Brain       Date:  1959-03       Impact factor: 13.501

4.  Myoclonus. Clinical significance and an approach to classification.

Authors:  B R AIGNER; D W MULDER
Journal:  Arch Neurol       Date:  1960-06

5.  A study of myoclonus.

Authors:  J P BRADSHAW
Journal:  Brain       Date:  1954       Impact factor: 13.501

6.  Nocturnal myoclonus.

Authors:  C P SYMONDS
Journal:  J Neurol Neurosurg Psychiatry       Date:  1953-08       Impact factor: 10.154

Review 7.  The clinical incidence of myoclonus.

Authors:  A M Halliday
Journal:  Mod Trends Neurol       Date:  1967

8.  Comparative trial of diazepam and pheneturide in treatment of epilepsy.

Authors:  H I Hershon; M Parsonage
Journal:  Lancet       Date:  1969-10-25       Impact factor: 79.321

9.  [Semeiology of myoclonus and analytic nosology of myoclonic syndromes].

Authors:  H Gastaut
Journal:  Rev Neurol (Paris)       Date:  1968-07       Impact factor: 2.607

10.  [Myoclonus of intent and myoclonus of action].

Authors:  P Castaigne; J Cambier; R Escourolle
Journal:  Rev Neurol (Paris)       Date:  1968-07       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.